What is Edwards Lifesciences Corp?
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL and EVOQUE brands. The company is listed on the NYSE in USA, operating in the Healthcare sector, with a market capitalisation of 58.56B, and a P/E ratio of 59.2x.
A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 11110,085 shares $10.9M | 0 |
| 3-6months | 938,787.39 shares $3.3M | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |